• About us
• Contact

Advertisement

Organisation › Details

Iontas Ltd.

IONTAS is a biotechnology company focused on antibody discovery and cutting-edge technology development. IONTAS offers services for antibody discovery using Phage Display Technology; and the supply of bespoke phage display libraries. In addition, IONTAS offers proprietary antibody discovery platforms including Mammalian Display where full length antibodies are expressed in the context of a mammalian cell thereby allowing selection based on function, stability, expression and developability; Iontas have also developed a novel “KnotBody” format which facilitates the targeting of antibodies to ion channels, GPCRs and proteases. *

 

	Start	2015-11-05 existent
	Group	FairJourney Biologics (FJB) (Group)
	Industry	therapeutic antibody
	Industry 2	drug discovery services
	Person	McCafferty, John (Iontas 201804 CEO)
	Person 2	Butt, Neil (Orbit Discovery 202106– CEO before Iontas + Abzena + Antitope)
	Region	Babraham, Cambridgeshire
	Country	United Kingdom (GB)
	Street	London Road Iconix Park
	City	CB22 3EG Pampisford, Cambridge
		Address record changed: 2024-01-05
Basic data	Employees	n. a.
		* Document for »About Section«: Iontas Ltd.. (4/4/18). "Press Release: Iontas and Igem Therapeutics Collaborate to Identify Novel IgE Antibodies for Cancer Targets". Cambridge.
		Record changed: 2023-07-10

Advertisement

More documents for FairJourney Biologics (FJB) (Group)

• [1] Orbit Discovery Ltd.. (6/29/21). "Press Release: Orbit Discovery Appoints Dr Neil Butt as Chief Executive Officer". Oxford....
• [2] Iontas Ltd.. (5/13/20). "Press Release: FairJourney Biologics Joins Forces with Iontas to Create a Global Leader in Outsourced Antibody Discovery Services". Porto & Cambridge....
• [3] Iontas Ltd.. (6/5/18). "Press Release: Iontas Signs Collaboration Agreement with LG Chem, Ltd. to Identify Therapeutic Oncology Leads". Cambridge & Seoul....
• [4] Iontas Ltd.. (5/30/18). "Press Release: Iontas Awarded £556K ($737K) from Innovate UK to Develop Therapies for Chronic Pain Management". Cambridge....
• [5] Iontas Ltd.. (5/2/18). "Press Release: Iontas and aTen Therapeutics Announce Collaboration to Discover Therapeutic Oncology Leads". Cambridge & Edinburgh....
• [6] Iontas Ltd.. (4/4/18). "Press Release: Iontas and Igem Therapeutics Collaborate to Identify Novel IgE Antibodies for Cancer Targets". Cambridge....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2024. Made in Germany.